Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments

Udaya S. Tantry, Eliano P. Navarese, Aung Myat, Rahul Chaudhary, Paul A. Gurbel

Research output: Contribution to journalReview article

Abstract

Introduction: There have been significant new developments in the treatment of patients with myocardial infarction with respect to oral antithrombotic agents over the past decade. Recent studies have explored the potential utility of targeting the dual pathway inhibition of platelet function with single or dual antiplatelet agents and the thrombin pathway with direct thrombin inhibitors or factor Xa inhibitors. Areas covered: In this review, the authors focus on the recent developments of oral antithrombotic agents including antiplatelet and antithrombin agents. It is based on literature covering: aspirin, P2Y12 receptor blockers, PAR-1 inhibitors, direct thrombin inhibitors and factor Xa inhibitors from PubMed since 2008. Expert opinion: Since thrombus formation involves multiple pathways including platelet activation and aggregation and coagulation, simultaneous and optimal blockade of these pathways is essential to prevent thrombotic complications and to avoid excessive bleeding in the myocardial infraction setting. Despite an improved anti-ischemic effect associated with potent P2Y12 inhibitors plus aspirin, the degree of adverse event reduction compared to clopidogrel therapy in large scale trials is modest along with significantly greater bleeding. Recent studies suggest that targeting the thrombin pathway in addition to antiplatelet agents in high risk patients may further mitigate the risk of ischemic event occurrences with improved safety profiles.

Original languageEnglish (US)
Pages (from-to)653-665
Number of pages13
JournalExpert Opinion on Pharmacotherapy
Volume19
Issue number7
DOIs
StatePublished - May 3 2018
Externally publishedYes

Keywords

  • aspirin
  • direct oral anticoagulant
  • Myocardial infarction
  • P2Y12 receptor inhibitor
  • platelet
  • rivaroxaban
  • thrombin

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments'. Together they form a unique fingerprint.

  • Cite this